Activated γδ T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells
Open Access
- 21 April 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 144 (3) , 528-533
- https://doi.org/10.1111/j.1365-2249.2006.03078.x
Abstract
γδ T cells account for up to 10% of T lymphocytes in the peripheral blood of healthy donors. They can be activated by cytokines such as interleukin (IL)-2, IL-12 and IL-15, express natural killer (NK) cell markers such as NKG2D and show cytotoxic activity against several tumour cells, including multiple myeloma. Here, we present activated polyclonal γδ T cells from healthy donors with an NK T cell-like phenotype expressing the natural cytotoxicity receptor NKp44. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 have been regarded as specific NK receptors; only two γδ T cell clones described so far expressed NKp44. Isolated polyclonal γδ T cells cultured for 7 days according to the cytokine-induced killer cell (CIK) protocol with additional IL-15 revealed a surface expression of NKp44 of 8 ± 7% (n = 22). This could be confirmed by detection of NKp44 mRNA by reverse transcription–polymerase chain reaction (RT–PCR). γδ T cells exhibited a marked cytotoxic activity against myeloma cells, which could be reduced by inhibition of NKp44. To our knowledge, this is the first description of the expression of NKp44 on polyclonal γδ T cells.Keywords
This publication has 38 references indexed in Scilit:
- Coculture with dendritic cells promotes proliferation but not cytotoxic activity of γ/δ T cellsImmunology Letters, 2005
- HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cellsBlood, 2005
- γδ T cells for immune therapy of patients with lymphoid malignanciesBlood, 2003
- Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activationNature, 2002
- Regulation of Cutaneous Malignancy by γδ T CellsScience, 2001
- Recognition of viral hemagglutinins by NKp44 but not by NKp30European Journal of Immunology, 2001
- Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer CellsThe Journal of Experimental Medicine, 1999
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- Human Peripheral γδ T Cells Are Stimulated by Daudi Burkitt's Lymphoma and Not by Any Other Burkitt's Lymphoma TestedCellular Immunology, 1994
- Two distinct human myeloma cell lines originating from one patient with myelomaInternational Journal of Cancer, 1985